A9V-25855-42223
1 vaccination
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 103 / NY
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Moderna
-
2021-03-05
Health check-in — day 0, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-07
- 2021-03-08
-
2021-09-03
Survey response — 6 months, dose 1MedDRA: Hyperthyroidism, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: hyperthyroidism · Healthcare visit (other): In office doctor visitMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-03
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-08
- 2022-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 6 months, dose 1
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Hyperthyroidism | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release